ETHAMBUTOL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Ethambutol Hydrochloride patents expire, and when can generic versions of Ethambutol Hydrochloride launch?
Ethambutol Hydrochloride is a drug marketed by Barr, Epic Pharma Llc, and Lupin. and is included in three NDAs.
The generic ingredient in ETHAMBUTOL HYDROCHLORIDE is ethambutol hydrochloride. There are five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethambutol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ethambutol Hydrochloride
A generic version of ETHAMBUTOL HYDROCHLORIDE was approved as ethambutol hydrochloride by EPIC PHARMA LLC on November 30th, 1999.
Summary for ETHAMBUTOL HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 121 |
Clinical Trials: | 112 |
Patent Applications: | 3,987 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in ETHAMBUTOL HYDROCHLORIDE? | ETHAMBUTOL HYDROCHLORIDE excipients list |
DailyMed Link: | ETHAMBUTOL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for ETHAMBUTOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tuberculosis Trials Consortium | Phase 2/Phase 3 |
University of Stellenbosch | Phase 2 |
University of California, Los Angeles | Phase 2 |
Pharmacology for ETHAMBUTOL HYDROCHLORIDE
Drug Class | Antimycobacterial |